We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats

    Myotonic dystrophy type 1 (DM1) is an RNA-dominant disease whose pathogenesis stems from the functional loss of muscleblind-like RNA-binding proteins...

    Ludovic Arandel, Magdalena Matloka, ... Denis Furling in Nature Biomedical Engineering
    Article 10 February 2022
  2. RNA Interference Ex Vivo

    RNA interference (RNAi) is a widely used technique to regulate the expression of genes and proteins with a high degree of specificity that is not...
    Shuang Liu in Rheumatoid Arthritis
    Protocol 2024
  3. Fortilin as a Biomarker in Toxicity

    Fortilin, the multifunctional protein, also known as translationally controlled tumor protein (TCTP), presents in most eukaryotic organisms. It is...
    Shreen D. Nusair in Biomarkers in Toxicology
    Reference work entry 2023
  4. Behavioural Effects and RNA-seq Analysis of Aβ42-Mediated Toxicity in a Drosophila Alzheimer’s Disease Model

    Alzheimer’s disease (AD) is the most common neurological ailment worldwide. Its process comprises the unique aggregation of extracellular senile...

    Florence Hui ** Tan, Ghows Azzam, ... Azalina Zainuddin in Molecular Neurobiology
    Article 05 May 2023
  5. Emerging role of RNA modification and long noncoding RNA interaction in cancer

    RNA modification, especially N6-methyladenosine, 5-methylcytosine, and N7-methylguanosine methylation, participates in the occurrence and progression...

    Liqiong Yang, Lu Tang, ... **g Shen in Cancer Gene Therapy
    Article Open access 14 February 2024
  6. The Role of RNA-Binding Proteins in Cancers

    RNA-binding proteins (RBPs) play fundamental roles in most aspects of cell regulation, specifically in post-transcriptional modifications, thanks to...
    Melika Shafeghat, Ashley Akrami, Nima Rezaei in Handbook of Cancer and Immunology
    Living reference work entry 2024
  7. Integrated mRNA- and miRNA-sequencing analyses unveil the underlying mechanism of tobacco pollutant-induced developmental toxicity in zebrafish embryos

    Tobacco pollutants are prevalent in the environment, leading to inadvertent exposure of pregnant females. Studies of these pollutants' toxic effects...

    Jiasheng Chen, Yuxin Lin, ... ** Zhong in Journal of Translational Medicine
    Article Open access 08 March 2024
  8. Strategies to reduce the risks of mRNA drug and vaccine toxicity

    mRNA formulated with lipid nanoparticles is a transformative technology that has enabled the rapid development and administration of billions of...

    Dimitrios Bitounis, Eric Jacquinet, ... Mansoor M. Amiji in Nature Reviews Drug Discovery
    Article 23 January 2024
  9. RNA Nanomedicine: Delivery Strategies and Applications

    Delivery of RNA using nanomaterials has emerged as a new modality to expand therapeutic applications in biomedical research. However, the delivery of...

    Junho Byun, Yina Wu, ... Yu-Kyoung Oh in The AAPS Journal
    Article 02 October 2023
  10. Nrf2-mediated ferroptosis of spermatogenic cells involved in male reproductive toxicity induced by polystyrene nanoplastics in mice

    Microplastics (MPs) and nanoplastics (NPs) have become hazardous materials due to the massive amount of plastic waste and disposable masks, but their...

    Xufeng Fu, Hang Han, ... **uying Pei in Journal of Zhejiang University-SCIENCE B
    Article 13 April 2024
  11. Frameworks for transformational breakthroughs in RNA-based medicines

    RNA has sparked a revolution in modern medicine, with the potential to transform the way we treat diseases. Recent regulatory approvals, hundreds of...

    John R. Androsavich in Nature Reviews Drug Discovery
    Article 13 May 2024
  12. RNA-dependent RNA polymerase (RdRp) natural antiviral inhibitors: a review

    Viral diseases are the cause of many global epidemics, leading to deaths, affecting the quality of life of populations, and impairing public health....

    Daniela Regina Buch Leite, Karen Mary Mantovani, ... Marilis Dallarmi Miguel in Medicinal Chemistry Research
    Article 29 September 2022
  13. Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity

    Identifying genetic modifiers of familial amyotrophic lateral sclerosis (ALS) may reveal targets for therapeutic modulation with potential...

    Craig L. Bennett, Somasish Dastidar, ... Albert R. La Spada in Acta Neuropathologica Communications
    Article Open access 17 October 2023
  14. Messenger RNA Nanovaccine in Cancer Immunotherapy

    During the past 2 years, messenger RNA (mRNA) nanovaccine has shown its remarkable antiviral efficacy, rapid manufacture, and good safety profile for...
    Mengyun Li, Hongxia Zhang in Cancer Nanotechnology
    Chapter 2023
  15. Toxicology and Toxicity Studies of Nano-Biomaterials

    The subject of nanotechnology has significant changes in the last 10 years as new applications of nanoparticles (NPs) and other nano-biomaterials...
    Raksha Rathore, Deepa Suhag, ... Preeti Thakur in Integrated Nanomaterials and their Applications
    Chapter 2023
  16. Amyloid Beta–Mediated Neurovascular Toxicity in Alzheimer’s Disease

    The brain vascular system receives one-fifth of the total oxygen from the cardiac output, and this transport system is highly dependent on...
    Sayani Banerjee, Sugato Banerjee in Neuroprotection
    Protocol 2024
  17. Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity

    Anti-tuberculosis (AT) medications, including isoniazid (INH), can cause drug-induced liver injury (DILI), but the underlying mechanism remains...

    Jihoon G. Yoon, Dong Geon Jang, ... Min Goo Lee in Experimental & Molecular Medicine
    Article Open access 01 March 2024
  18. Amplifying gene expression with RNA-targeted therapeutics

    Many diseases are caused by insufficient expression of mutated genes and would benefit from increased expression of the corresponding protein....

    Olga Khorkova, Jack Stahl, ... Claes Wahlestedt in Nature Reviews Drug Discovery
    Article 30 May 2023
  19. Ceria nanoparticles: biomedical applications and toxicity

    Ceria nanoparticles (CeO 2 NPs) have become popular materials in biomedical and industrial fields due to their potential applications in...

    **aoxuan Fu, Peng Li, ... Zhuhong Zhang in Journal of Zhejiang University-SCIENCE B
    Article 17 May 2024
  20. Toxicity evaluation of silica nanoparticles for delivery applications

    Silica nanoparticles (SiNPs) are being explored as nanocarriers for therapeutics delivery, which can address a number of intrinsic drawbacks of...

    Yue Tan, Dawei Yu, ... Zhengquan Su in Drug Delivery and Translational Research
    Article 06 April 2023
Did you find what you were looking for? Share feedback.